GLOBUS GROWTH GROUP INC
10-K, 1997-05-29
INVESTORS, NEC
Previous: SMITH BARNEY SHEARSON FUNDAMENTAL VALUE FUND INC, NSAR-A, 1997-05-29
Next: BROWN ALEX CASH RESERVE FUND INC, NSAR-B, 1997-05-29




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549
                                    FORM 10-K


(X)  ANNUAL REPORT  PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES  EXCHANGE
     ACT OF 1934 -- For the fiscal year ended February 28, 1997

                                       OR

( )  TRANSITION  REPORT  PURSUANT  TO SECTION 13 OR 15 (d) OF THE  SECURITIES
     EXCHANGE ACT OF 1934

Commission file number 0-9987

                            GLOBUS GROWTH GROUP, INC.
             (Exact name of registrant as specified in its charter)

                  New York                              13-2949462
         (State of incorporation)            (I.R.S Employer Identification No.)

44 West 24th Street, New York, NY                             10010
(Address of principal executive offices)                    (Zip Code)

Registrant's telephone number, including area code - (212) 243-1000
Securities registered pursuant to Section 12(b) of the Act:  None
Securities registered pursuant to Section 12(g) of the Act:
         Common Stock, $.01 Par Value
                  (Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes (X ) No

Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K (X)

The aggregate market value of the voting stock held by  non-affiliates as at May
1, 1997 was  approximately  $65,509  (524,068  shares at $.125 per  share).  The
number of shares of the Registrant's  Common Stock outstanding as at May 1, 1997
was 2,364,860 (excluding 134,140 shares held in the Registrant's  treasury).  Of
the  outstanding  shares,  a  total  of  1,840,792  are  deemed  to be  held  by
affiliates.  The  referred to market  value was  computed by  reference to a bid
price of $.125  per  share  contained  in the  "Pink  Sheets"  published  by the
National  Quotation  Bureau dated May 1, 1997 (there being no published price at
which the stock was sold, or any published  average bid and asked prices of such
stock as of such date).

                   DOCUMENTS INCORPORATED BY REFERENCE - None

                                                This report consists of 27 Pages

<PAGE>


                                     PART I


Item 1.  BUSINESS

General Background

     The Company, a New York corporation,  was organized on August 6, 1976 under
the name of  Globuscope,  Inc. On August 7, 1984, its name was changed to Globus
Growth Group, Inc., which is its present name.

     On  February  27,  1986,  the  stockholders  of the  Company  approved  the
divestiture  and sale of those  assets of the Company as  pertained  to its then
camera  manufacturing and photography  operations as well as the sale of certain
shares of stock in a photographic  related  company owned by it and its interest
in the Company's then owned  premises.  The sale was  consummated as of February
28, 1986.  After such  divestiture,  the Company's  activities  consisted of the
holding of interests in various companies and the seeking out of acquisition and
joint-venture  opportunities in various fields of business endeavor.  On May 31,
1988,  the  Company  filed  with  the  Securities  and  Exchange   Commission  a
notification  of  election  to be treated as a  "Business  Development  Company"
("BDC") as that term is defined in the Investment Company Act of 1940 (the "1940
Act"). For a summary description of certain  restrictions  imposed upon a BDC by
the 1940 Act,  reference should be made to "Governmental  Regulation"  elsewhere
herein. For a summary  description of the risk factors involved in an investment
in the  securities  of a BDC due to the  nature of such a  company's  investment
portfolio,  reference should be made to "Risk Factors Involved In Investing In A
BDC" elsewhere herein.

Investment Portfolio

     As at February 28,  1997,  the Company held  investments  in the  following
investee  companies:  (investments  listed include only those the value of which
have not been written down to zero).

(i) Catamount Brewing Company - a privately held beer brewing company located in
White River Junction,  Vermont.  Operations of the brewery  commenced on January
22, 1987, and the plant is presently  operating at full  capacity.  Sales of the
product are  presently  being made  principally  in Vermont,  New  Hampshire and
Massachusetts.  A small  secondary  sales  market for the product also occurs in
parts of Connecticut,  New York, Rhode Island,  New Jersey and Washington,  D.C.
Richard D. Globus,  an officer and director of the Company is also a director of
Catamount,  and various members of the Globus family,  two of whom are Directors
of the  Company,  as well as one other  member of the Board of  Directors of the
Company are also stockholders of Catamount.

(ii) Interface Systems, Inc. - a publicly held company that provides interfacing
solutions for proprietary  computer  architectures  (such as IBM mainframes) and
other peripheral devices such as printers, PC's, cash registers and open systems
computers. Its products consist of hardware and proprietary software;  including
a  laser  printer  product  line  and  software  that  interfaces  a  Unix-based
workstation with an IBM mainframe.  Various members of the Globus family, two of
whom are Directors of the Company, are also stockholders of Interface.

(iii)  Nematron  Corporation - in February,  1993, the Company  received  16,925
shares of Nematron Corporation,  formerly a wholly owned subsidiary of Interface
Systems,  as a "spin-off"  distribution from Interface.  Nematron is principally
engaged  in  the  design,  manufacture  and  marketing  of  industrial  products
consisting  primarily of industrial computers and industrial terminals which are
used  for the  purpose  of  industrial  manufacturing  and  process  automation,
specifically as it relates to operator-machine interface applications. By reason
of the "spin-off" distribution,


<PAGE>


Nematron is presently a publicly held company. A Director of the Company as well
as various  members  of the  Globus  family,  two of whom are  Directors  of the
Company, are also stockholders of Nematron.

(iv) Energy  Research  Corp. - a designer and  manufacturer  of various types of
energy storage, supply and generating devices and systems; including fuel cells,
which is a device that converts the energy of a fuel directly to electricity and
heat without combustion.  In July, 1992 such Company completed an initial public
offering of its securities.

(v) Kimeragen, Inc. - a privately held non-affiliated  development stage company
founded in 1994 for the purpose of engaging in research and  development  in the
field of developing  gene therapy  products for the treatment of hereditary  and
acquired diseases.

(vi)  Repligen   Corporation   ("Repligen")  -  a  publicly  held  research  and
development  corporation  founded in 1981.  Its field of activity  is  primarily
focused on the  development of new therapies for chronic and acute  inflammation
and immunosuppression and the development of enabling technologies for discovery
of new drugs by rapid screening of combinatorial chemical libraries. In March of
1996,  Repligen  acquired  Glycan  Pharmaceuticals  ( a former  investee  of the
Company). As a result of that transaction, Repligen acquired a majority interest
in Proscure,  Inc. (another former investee of the Company).  Subsequently,  the
Company exchanged its interests in Proscure, Inc. and Glycan Pharmaceuticals for
an aggregate of 100,468 shares of Common Stock of Repligen. One of the Directors
of the Company, who was a stockholder of Proscure, Inc. is also a stockholder of
Repligen. For additional information concerning Proscure, Inc. reference is made
to Item 1 of the Company's Form 10-K for its fiscal year ended February 29, 1996
and to Note B of the Notes To Financial  Statements contained in such Form 10-K,
which Item and Note are incorporated herein by reference.

(vii) Genitope  Corporation - a privately held research and development  company
that holds  proprietary  technology  having  applications in the field of cancer
therapy.  It intends to initially  focus upon the  development and production of
custom cancer vaccines for the treatment of "B Cell" and "T Cell"  Non-Hodgkin's
Lymphoma.

(viii)  Woodstock  Communications,  Inc. - a privately  held company that claims
certain  trademark  rights to the name  "Woodstock"  for  radio  and  television
broadcasting.  It  presently  intends  to create  and  acquire  music,  talk and
information  programming and to pursue three main business areas -- local radio,
the  Internet  and  Merchandising  and  Licensing.  One of the  Directors of the
Company,  (Mr.  Ronald J. Frank) is a 5%  stockholder  of Woodstock as well as a
consultant  and a lender to it.  Such person is also  presently  Chairman of the
Board of Directors of Woodstock.

     No  representation is made by the Company that any or all of its investees:
(a) has, or will have in the immediate  future,  sufficient funds to continue to
carry  on  business  activities;  (b)  will  be  able to  achieve  any of  their
respective  business  objectives;  (c)  will  be  able to  achieve  or  maintain
profitable  operations;  or (d)  will  not  be  obliged  to  attempt  to  obtain
additional funding.
 

     For  additional   information   concerning  each  of  the  above  specified
investments,  reference  should  be  made to Note B of the  Notes  to  Financial
Statements contained elsewhere herein.


<PAGE>


Valuation of Investments

     Investment  are  carried  at fair  value,  which,  for  readily  marketable
securities,  represents  the  last  reported  sales  price  or bid  price on the
valuation date.  Investments in restricted  securities and securities  which are
not readily  marketable are carried at fair value as determined in good faith by
the Board of  Directors,  in the  exercise of its  judgment,  after  taking into
consideration  various  indications  of value  available to the Board.  See also
Notes A and B of Notes To Financial Statements elsewhere herein.

     The following table, and the footnotes thereto, set forth certain specified
information  concerning the  investments of the Company as at February 28, 1997,
and as to the valuations thereof,  specified in dollars, ascribed to them by the
Board of  Directors  of the Company as at such date.  For  comparative  purposes
only, the valuations (as  applicable)  ascribed as at February 29, 1996 are also
set  forth.  Investments  listed in the table  include  only  those the value of
which,  as at February 28, 1997, had not, then or previously,  been written down
to zero or disposed of. The table and notes should be read in  conjunction  with
Notes A and B of Notes To Financial Statements elsewhere herein. (Amounts are in
dollars and are rounded to the nearest thousand.)

                                                                        Basis
                                         2/28/97          2/29/96      Employed
                                         -------          -------      --------
Catamount Brewing Company            $  569,000(1)    $  176,000(1)   Fair Value
Interface Systems, Inc.              $    4,000(2)    $   12,000(2)   Market
Nematron Corporation                 $  110,000(3)    $  127,000(3)   Market
Energy Research Corp.                $  883,000(4)    $  891,000(4)   Market
Proscure, Inc.                       $        0       $  173,000(5)   Fair Value
Glycan Pharmaceuticals, Inc.         $        0       $   17,000(6)   Fair Value
Kimeragen, Inc.                      $  805,000(7)    $  294,000(7)   Fair Value
Repligen, Inc.                       $   86,000(8)    $        0      Market
Genitope Corp.                       $  130,000(9)    $        0      Fair Value
Catamount Brewing Co. Pfd.           $  150,000(10)   $        0      Fair Value
                                     -------------    ----------                
                                     $2,737,000       $1,690,000      
                                     -------------    ----------
Notes to Table:

(1) Represents equity investment - 23,215 shares owned at each date.

(2) Represents equity investment - 775 shares owned at each date.

(3) Represents equity investment - 16,925 shares owned at each date.

(4)  Represents  equity  investment - 76,000  shares owned at 2/28/97 and 81,000
owned at 2/29/96.

(5)  Represents  equity  investment  - 61,000  shares  of  Series A  Convertible
Preferred Stock; 75,000 Common Stock Purchase Warrants  exercisable until August
31, 2000 at $3.75 per share; and 53,334 shares of Series B Convertible Preferred
Stock owned at 2/29/96; exchanged for Repligen on 12/18/96.

(6)  Represents  equity  investment  - 37,500  Common  Stock  Purchase  Warrants
exercisable  until June 23, 2000 at $4.50 per share owned at 2/29/96;  exchanged
for Repligen on 12/18/96.

(7)  Represents  equity  investment - 108,827 shares of Class A Common Stock and
35,000 shares of Class B Common Stock owned at 2/28/97;  and 414 Common  shares,
55,000 shares of Class A Common Stock,  and 113 shares of Preferred  Stock owned
at 2/29/96.

(8)  Represents equity investment - 100,468 shares owned at 2/28/97.

(9) Represents  equity  investment - 260,000 Series A Preferred  shares owned at
2/28/97.

(10) Represents  equity  investment - 4,286  Preferred  shares owned at 2/28/97.


<PAGE>


Because of valuation factors, increases or decreases in the dollar amount of any
particular investment, business judgment, and other investment decision factors,
the amount of the Company's  interest in any  particular  investee may vary from
time to time.

     The preceding table does not include the Company's  investment in Woodstock
Communications,  Inc.,  which  investment  consists of a Promissory Note of such
entity in the amount of $50,000 dated  November 19, 1996  representing a loan to
it by the Company in such amount.  The maturity date of such Note is the earlier
to  occur  of  November  19,  1998 or the date of  consummation  of a  corporate
financing by Woodstock in an amount exceeding $1,750,000.  On the maturity date,
the Company has the right to elect to receive (by way of interest) either a cash
interest payment of 10% simple interest per annum, or, in lieu of cash interest,
a number of shares of Class A Common Stock of Woodstock equating to 1% ownership
interest  in  Woodstock  on the date of the Note,  subject to  certain  dilutive
effects of subsequent transactions.

Governmental Regulation

     The 1940 Act imposes many and varied  restrictions  on the  activities of a
BDC, including restrictions on the nature of its investments. Some, but not all,
of the restrictions imposed on the activities of a BDC by such Act are described
in the following three paragraphs.

     Generally speaking,  the 1940 Act prohibits a BDC from investing in certain
types of companies,  such as brokerage firms,  insurance  companies,  investment
banking firms and investment companies.  Moreover,  the 1940 Act limits the type
of assets that a BDC may  acquire to  "qualifying  assets"  and  certain  assets
necessary  for  its  operations  (such  as  office   furniture,   equipment  and
facilities)  if, at the time of  acquisition,  less than 70% of the value of its
assets consist of qualifying assets.  Qualifying assets include:  (i) securities
of companies that were eligible portfolio companies (as defined in the 1940 Act)
at the time that the BDC acquired their securities;  (ii) securities of bankrupt
or insolvent  companies  that are not otherwise  eligible  portfolio  companies;
(iii)  securities  acquired as  follow-on  investments  in  companies  that were
eligible at the time of the BDC's initial  acquisition  of their  securities but
are no longer  eligible,  provided  that the BDC has  maintained  a  substantial
portion of its initial investment in those companies;  (iv) securities  received
in exchange for or distributed  in or with respect to any of the foregoing;  and
(v) cash items, Government securities and high-quality short-term debt. The 1940
Act also places restrictions on the nature of the transactions in which, and the
persons from whom, securities can be purchased in order for the securities to be
considered qualifying assets.

     A BDC is permitted,  under specified conditions,  to issue multiple classes
of senior debt and a single class of preferred stock if its asset  coverage,  as
defined  in such Act,  is at least 200%  after the  issuance  of the debt or the
preferred stock.

     A majority  of the members of the Board of  Directors  of a BDC must not be
"interested  persons"  of the BDC as that term is defined in the 1940 Act.  Most
transactions  involving a BDC and its affiliates (as well as affiliates of those
affiliates)  require the prior  approval of a majority of the BDC's  independent
directors and a majority of the directors  having no financial  interest in such
transactions.  Some transactions involving certain closely affiliated persons of
the BDC,  including its  directors,  officers and  employees,  still require the
prior approval of the Securities and Exchange Commission (the "Commission").  In
general,  (a) any person who owns,  controls,  or holds with power to vote, more
than 5% of a BDC's outstanding Common Stock, (b) any director, executive officer
or general partner of that person, and (c) any person who directly or indirectly
controls,  is controlled by, or is under common control with, that person,  must
obtain the prior  approval  of the BDC's  independent  directors,  and,  in some
instances,  the prior  approval of the  Commission,  before  engaging in certain
transactions involving the BDC or any company controlled by the BDC.


<PAGE>


Risk Factors Involved In Investing In A BDC

     Due to the nature of the usual investment portfolio of a BDC similar to the
limited size and scope of the Company, an investment in the securities of such a
BDC involves a degree of risk that exceeds the risks involved in investing in an
operating company. Since the Company has elected to become a BDC, such risks are
now  applicable  to the  securities  of the Company.  The  following,  generally
speaking, includes some, but not all, of such risks:

     (a) The usual  principal  business  objective of a BDC is to seek long-term
capital appreciation by making venture capital investments  primarily in new and
developing companies which management of the BDC believes offer significant long
term potential for capital appreciation.

     (b) An investment in a development stage company or in a new and developing
company  subjects  the BDC to a number of the same risks to which such  investee
entity  is  subject,   namely:   (i)  the  problems,   expenses,   difficulties,
complications  and delays  that can be  expected  to be  encountered  by such an
entity in connection  with the attempted  development of a  commercially  viable
product and bringing  such product to market,  (ii) possible need by such entity
of additional financing, (iii) competition encountered by such entity, including
competition  from companies  with greater  financial  resources,  more extensive
development,  manufacturing,  marketing  and service  capabilities  and a larger
number of qualified managerial and technical personnel.

     (c) Many of the securities  acquired by a BDC are  "restricted  securities"
within the meaning of the Securities Act of 1933  ("Securities  Act") and cannot
be resold without  compliance  with the  Securities  Act. Such  restrictions  on
resale will most likely adversely affect the liquidity and marketability of such
securities.  Registration for sale of restricted securities under the Securities
Act is within the sole province of the issuer  concerned.  Such  registration is
likely to be a time-consuming and expensive process and the BDC in certain cases
may have to bear the expense of such  registration.  In  addition,  a BDC always
bears the risk, because of the delays inherent in the registration process, that
it will be unable to resell  the  securities  held by it, or that it will not be
able to obtain an  attractive  price for them. In the event the BDC is unable to
cause the securities to be registered  for resale,  it will have to seek to rely
upon  an  exemption  from  registration.   Among  other  exemptions,   Rule  144
promulgated  under the Securities Act imposes a one-year holding period prior to
the sale of restricted  securities  and  establishes  volume  limitations on the
amount of any restricted securities that can be sold within certain defined time
periods.  Furthermore,  there cannot be any assurance  that there ever will be a
market for the  securities  held by a BDC; or if a market should  develop,  that
such  market  will be an  established  market  and able to absorb  the sale of a
sizable amount of securities.

     (d) It may become  necessary  to make  additional  investments  in investee
companies so as to protect a prior  investment.  Such follow-on  investments may
limit  the  number  of  companies  in which a small  size BDC has the  financial
ability to invest.  Furthermore, a BDC with limited funds available may not have
sufficient funds to make as many follow-on investments as it deems necessary and
any  follow-on  investments  which it makes may not be sufficient to protect its
prior  investments  in such  entity,  with  the  result  that it may  experience
significant  losses in such  investments.  A decision  not to make a  particular
follow-on investment, or the financial inability to make it, may have a material
adverse impact on the investee.

     (e) A BDC  similar  in size  and  scope  to the  Company  is a  "closed-end
non-diversified  company"  as that term is defined  in the 1940 Act.  Such small
size  prevents  it from  being able to commit  its funds to the  acquisition  of
securities  of a large  number of  companies  and prevents it from being able to
achieve the same type of  diversification  as larger entities engaged in venture
capital  activities.  Furthermore,  such small size  places it at a  competitive
disadvantage with other venture capital investing entities that have far greater
financial resources available.


<PAGE>


     (f) The  investment  objective  of a BDC  similar  in size and scope to the
Company is  long-term  capital  appreciation.  To the extent  that any income is
derived  from  operations,  it is likely  that it will be used  entirely to fund
additional  investments  and  continuing  working  capital  needs rather than be
distributed to stockholders.

     (g) In order to  increase  its  ability  to  invest in  eligible  portfolio
companies,  a BDC similar in size and scope to the Company may borrow monies and
pay interest on such  borrowings.  Any investment gains made with the additional
monies in excess of  interest  paid will cause the net asset  value of the BDC's
stock to rise faster than would otherwise be the case. On the other hand, if the
investment  performance of the additional  securities  purchased  fails to cover
their cost  (including any interest paid on the money  borrowed),  the net asset
value of the BDC will decrease  faster than would otherwise be the case. This is
known as "leveraging."
 
     For further details  concerning the financial  condition of the Company and
its  ability  to make  investments,  reference  should be made to  "Management's
Discussion  and  Analysis of  Financial  Condition  and  Results of  Operations"
elsewhere herein.

Personnel

     The Company presently employs three persons (including Messrs.  Stephen and
Richard Globus) on a full-time basis and one person on a part-time basis.

Item 2. PROPERTIES

     The Company continues to occupy office space at the premises formerly owned
by it (44 West 24th Street,  New York, New York). While no formal lease was ever
entered  into with Idex (now  Globus  Studios,  Inc.) the  Company is  presently
paying a charge of $1,185 per month;  which  charge  includes  office  space and
electricity.

Item 3.  LEGAL PROCEEDINGS

     Not Applicable.

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     Not Applicable.


                                     PART II

Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCK HOLDER MATTERS.

     (a)  Market  information.  The  Company's  Common  Stock is  traded  in the
over-the-counter  market.  Prior to February  11,  1991,  such Common  Stock was
quoted by the National  Association of Securities  Dealers  Automated  Quotation
System (NASDAQ), but such quotation was discontinued on February 11, 1991. While
quotations are presently  available  from a dealer upon request,  the market for
the Company's Common Stock would not appear to qualify as an "established public
trading  market" as such term is defined in Securities  and Exchange  Commission
regulations.  High and low bid prices for the Common  Stock of the Company  have
not been published by recognized  sources since quotations on NASDAQ  terminated
and  Management  of the  Company is not aware of such  prices for the  quarterly
periods within the past two fiscal years except that: (i) the


<PAGE>


National Stock Summary Guide,  published by the National  Quotation Bureau,  has
published quotations for the Company's Common Stock on a monthly and semi-annual
basis to the extent that same are available; (ii) the "Pink Sheets" published by
the National  Quotation  Bureau  publishes  quotations for the Company's  Common
Stock on a daily basis to the extent that same are  available;  (iii) such "Pink
Sheets" dated May 1, 1997,  indicate a bid price of $.125 per share but no asked
price;  (iv) in April 1996, the Company acquired in the open market 1,000 shares
of Common Stock for its treasury at a cost of approximately  $.17 per share; (v)
such "Pink  Sheets"  dated  February 29, 1996,  indicate a bid price of $.25 per
share but no asked  price;  and (vi) such "Pink  Sheets"  dated March 10,  1997,
indicate a bid price of $.125 per share but no asked price.  Generally speaking,
the "Pink  Sheets"  published by the National  Quotation  Bureau,  Inc.  reflect
inter-dealer  prices,  without retail mark-up,  mark-down or  commissions,  and,
unless otherwise specified, do not represent actual transactions.

     (b)  Holders.  The number of  holders of record of the Common  Stock of the
Company as of May 7, 1997, was approximately 218.

     (c)  Dividends.  No  dividends on the Common Stock have been paid since the
organization of the Company.


Item 6. SELECTED FINANCIAL DATA

     The  following  selected  financial  information  was  abstracted  from the
financial  statements of the Company  appearing  elsewhere  herein and reference
should be made to such statements for more details:  (All figures are in dollars
and are rounded)

<TABLE>
<CAPTION>
                                                                                    Year Ended

                                                   2/28/97          2/29/96            2/28/95            2/28/94            2/28/93
                                                   -------          -------            -------            -------            -------
<S>                                                <C>             <C>                 <C>               <C>                 <C>    
Statement of Operations:
Gain (loss)
  on investments                                   819,000         1,304,000           225,000           (423,000)           747,000
Interest and Dividend
 Income                                             42,000             8,000             8,000                  0                  0

Consulting and other
  income                                            50,000            68,000            25,000             27,000             22,000
Earnings (loss)                                    647,000         1,130,000           (29,000)          (672,000)           549,000

Per share:
Earnings (loss)                                        .27               .47              (.01)              (.28)               .23

Cash dividends                                         -0-               -0-               -0-                -0-                -0-

Balance sheet:
Total assets                                     3,318,000         2,691,000         1,568,000          1,581,000          1,956,000

Shareholders' equity
  (capital deficiency)                           1,475,000           829,000          (299,000)          (270,000)           402,000
</TABLE>


Item 7. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Results of Operations  --- Prior to fiscal 1987,  the Company was engaged in the
camera and  photography  business.  On February 28,  1986,  the Company sold its
operating business to an affiliated company and


<PAGE>


since  that  date the  Company's  principal  activity  has been  the  making  of
investments in other companies.

     At February 28, 1997, the Company had total assets of $3,318,000,  compared
to  $2,691,000  as at February 29, 1996 and  $1,568,000 as at February 28, 1995.
Included in total assets at such dates were  investments  of $2,787,000  (1997),
$1,690,000 (1996) and $1,489,000 (1995).  Shareholders' equity at such dates was
$1,475,000 (1997),  $829,000 (1996) and ($299,000)  (1995).  Gain on investments
for such periods  amounted to $819,000  (1997),  $1,304,000  (1996) and $225,000
(1995).  Included in such gains were  $46,000 of realized  gains and $773,000 of
unrealized gains for 1997; $859,000 of realized gains and $445,000 of unrealized
gains for 1996; and $203,000 of realized  gains and $22,000 of unrealized  gains
for 1995. Operating expenses,  including interest charges,  amounted to $264,000
for 1997;  $250,000  for 1996 and  $287,000  for  1995.  Included  in  operating
expenses were interest charges of $35,000 for 1997, $53,000 for 1996 and $50,000
for 1995.  Income (loss) from  operations,  both before and after  provision for
taxes,  was $647,000 for 1997;  $1,130,000  for 1996 and ($29,000) for 1995. Net
earnings  (loss)  per share  were $. 27 for 1997;  $.47 for 1996 and  ($.01) for
1995. The weighted average number of shares of Common Stock  outstanding at such
dates was 2, 364,964 for 1997, 2,380,208 for 1996 and 2,395,477 for 1995.

Liquidity, Capital Resources and Other Matters Affecting Financial Condition
 
     The  Company's  cash  position as at February 28, 1997 (i.e.,  $512,000) is
offsetable by approximately $ 1,793,000 owing to members of the Globus family as
follows:  (i) the  amount  of loans  payable  at such  date  (including  accrued
interest)  to Messrs.  Stephen E. and  Richard D.  Globus  (i.e.,  approximately
$528,000);  (ii) the  amount of loans  payable at such date  (including  accrued
interest) to Ms. Jane Globus,  the mother of Stephen and Richard  Globus  (i.e.,
approximately  $405,000);  and (iii) the amount of accrued  salary owing at such
date to Stephen and Richard Globus,  aggregating  approximately $860,000. During
the past fiscal year Mr. Stephen Globus' loan account was reduced by payments to
him of $35,200 and Mr.  Richard  Globus' loan account was reduced by payments to
him of $45,200.  Subsequent to February 28, 1997,  the loan payable  account for
Mr.  Stephen E. Globus and Mr. Richard D. Globus was reduced by payments to them
of $35,000 and $25,000, respectively.

     The near term  liquidity of the  Company,  as well as its near term capital
resources  position,  are presently  principally  dependent upon: (i) the market
value and  future  ability  of the  Company  to sell its  position  in  Nematron
Corporation; (ii) the market value and future ability of the Company to sell its
position in Energy Research  Corporation  (which position is also subject to the
provisions  of Rule  144 (k)  under  the  Securities  Act of  1933);  (iii)  the
continued willingness,  as to which there can be no assurance whatsoever, of the
members of the Globus  family who have made loans to the  Company  not to demand
full or  substantially  full  repayment  of such loans;  and (iv) the  continued
willingness, as to which there can be no assurance whatsoever, of the members of
the Globus  family who have made loans to the  Company to continue to make loans
to  the  Company  if  necessary.  See  also  Note A (1) of  Notes  to  Financial
Statements elsewhere herein.

     In connection with Interface Systems, Inc. and Energy Research Corporation,
it should be noted that during the past  fiscal  year,  the  Company  sold 5,000
shares of its holdings in Energy Research Corporation (realizing net proceeds of
approximately $52,184). Such proceeds,  aggregating  approximately $52,184, were
principally  applied  by the  Company as  follows:  $50,000  Promissory  Note in
Woodstock  Communications.  Reference  should also be made to the  Statements of
Cash Flows contained in the Financial Statements appearing elsewhere herein.

     In  connection  with  loans  payable  by  the  Company,  including  accrued
interest,  to  Messrs.  Stephen  E. and  Richard D.  Globus,  such  indebtedness
aggregated:  approximately $762,000 at February 28, 1995; approximately $660,000
at February 29, 1996 and approximately  $528,000 at February 28, 1997. As at May
7, 1997, such indebtedness aggregated approximately $456,000, of


<PAGE>


which amount approximately  $364,000 was owed to Stephen E. Globus. As at May 7,
1997 the  indebtedness  owing  by the  Company  to Ms.  Jane  Globus  aggregated
approximately  $409,000.  As at May 7, 1997,  unpaid  salaries  owing to Messrs.
Stephen E. and Richard D. Globus aggregated  approximately  $872,500; so that as
at such date the total of monies owed to Messrs.  Stephen E. Globus,  Richard D.
Globus and Ms. Jane Globus aggregated approximately $1,737,500.

     There  are in  fact  presently  no  known  events  that  can be  considered
reasonably  certain to occur which would materially  change favorably either the
short term or long term  liquidity  (i.e.,  ability of the  Company to  generate
adequate  amounts  of cash to meet its  needs  for  cash) or  capital  resources
position (i.e.,  source of funds) of the Company from that in which it presently
finds itself, and, absent possible sales of stock of Energy Research Corporation
and of Nematron  Corporation and  continuation  of the presently  existing loans
without call for full or substantially full repayment,  or additional loans from
the Globus family,  the present liquidity and capital resources  position of the
Company necessarily adversely affects the financial condition of the Company and
its ability to make new investments.  (In such connection it must be noted that:
the  profitability  of a BDC, like the Company,  is largely  dependent  upon its
ability to make  investments and upon increases in the value of its investments;
and a BDC is also subject to a number of risks which are not  generally  present
in an operating  company,  and which are  discussed  generally in Item 1 of this
Report to which Item reference should be made.)

     The nature and extent of the Company's  investments as at February 28, 1997
are more  fully  discussed  in Item 1 of this  Report  and in Note A of Notes to
Financial  Statements elsewhere herein and reference should be made to such Item
and such Note.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

     Not Applicable.

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 
     The  information  required  by Item 8  appears  at pages F-1  through  F-11
(inclusive)  of this  Report,  which pages  follow Item 14 of this  Report.  The
following is an Index to the referred to Financial  Statements and Supplementary
Data:

Report of Independent Auditors
         ((Richard A. Eisner & Company LLP)                              F-1
Balance Sheets as at February 28, 1997 and February 29, 1996             F-3
Statements of Operations
         For the Three Years Ended February 28, 1997                     F-4
Statement of Changes in Shareholders' Equity
         For the Three Years Ended February 28, 1997                     F-5
Statement of Cash Flows
         For the Three Years Ended February 28, 1997                     F-6
Notes to Financial Statements                                            F-7
Financial Data Schedule                                                  Page 27

     All schedules  supporting financial statements are omitted because they are
not  applicable  or the  required  information  is  included  in  the  financial
statements or notes thereto.

Item  9.  CHANGES  IN AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
FINANCIAL DISCLOSURE

         Not Applicable.


<PAGE>


                                    PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

         Stephen E. Globus                  Chairman of the Board
         Richard D. Globus                  President and Director
         Stanley Wunderlich                 Director
         Ronald J. Frank                    Director
         Joseph Mancuso                     Director
         Lisa Vislocky                      Vice President and Treasurer

Note:  The office of Secretary  of the Company  does not have any  policy-making
function, and accordingly,  Mr. Harry Balterman, who is the Secretary, is not an
Executive Officer of the Company.

     STEPHEN E. GLOBUS,  age 50, has been an officer and director of the Company
since its  organization  in 1973, and is currently its Chairman of the Board and
Chief Executive Officer. He is also a director of Tinsley Laboratories, Inc. and
Plasmaco, Inc.

     RICHARD D. GLOBUS,  age 50, as well as his brother  referred to above,  has
also been an officer and director of the Company since its organization in 1973,
and is  currently  its  President  and  Chief  Operating  Officer.  He is also a
director of Globus Studios,  Inc.  (formerly Idex,  Inc.) and Catamount  Brewing
Company.

     STANLEY WUNDERLICH,  age 51, holds a BS degree from Brooklyn College and an
LL.B.  degree from LaSalle Law School.  He is presently,  and has been since the
beginning  of 1995,  engaged in  investment  banking  and  financial  consulting
activities for various  organizations.  From 1991 until 1994 he was the Managing
Director of the Institutional Services Department of Robert Todd Financial Corp.
(an investment  banking firm). From 1977 until 1987, he was Managing Director of
Krieger, Wunderlich,  Fialkov, Scheinman & Co. (a broker-dealer);  and from 1972
until 1977 he was a Vice President of Blyth, Eastman, Dillon Union Securities (a
broker-dealer).  He is a  former  member  of the  Arbitration  Committee  of the
American  Stock Exchange and a former Vice President of the Long Island Forum of
Technology. Mr. Wunderlich is a director of C.P.I.  Aerostructures Corp. and has
been a director of the Company since his election as such on December 3, 1992.

     RONALD J.  FRANK,  age 47, is  presently,  and has been since June 1990,  a
private investor.  From January 1989 to June 1990, he was associated with Profit
Concepts,  Ltd.,  which was a general  partner of an investment  partnership and
from March 1987 to January 1989 he was a private financial consultant. Mr. Frank
has been a director  of the  Company  since his  election as such on December 3,
1992.

     JOSEPH  MANCUSO,  age 57,  holds  an  Electrical  Engineering  degree  from
Worcester  Polytechnic  Institute  in  Massachusetts,  an MBA from  the  Harvard
Business  School  and  a  Ph.D.  in  Educational   Administration   from  Boston
University.  He has been Chairman of the  Management  Department in  Educational
Administration at Worcester  Polytechnic  Institute and is presently the head of
the Center  for  Entrepreneurial  Management,  Inc.  and of the Chief  Executive
Officers  Club in New York  City.  Mr.  Mancuso  is the  author  of a number  of
business plan books which have been  published by Simon & Schuster.  Mr. Mancuso
is a director of Interscience Corp. and has been a director of the Company since
his election as such on December 3, 1992.


<PAGE>


     LISA  VISLOCKY,  age 39,  is a  Certified  Public  Accountant  and has been
employed by the Company,  on a full-time basis, since March 1986. From September
1983 until  February  1986,  she was employed by Weiner and  Company,  Certified
Public  Accountants  and from 1979 to May 1983 she was an  internal  auditor for
International Telephone & Telegraph Co., Inc.

     Messrs.  Wunderlich,  Frank and Mancuso are considered to be the members of
the Board of Directors  of the Company who are the  "independent  directors"  as
required by the Investment  Company Act of 1940. (See the caption  "Governmental
Regulation" in Item 1 above.)

     Directors are elected at the annual meeting of stockholders and hold office
until  the  following  annual  meeting.   The  most  recent  annual  meeting  of
stockholders  was held on December 3, 1992. The terms of all officers  expire at
the annual  meeting of  directors  following  the annual  stockholders  meeting.
Subject  to their  contract  rights to  compensation,  if any,  officers  may be
removed at any time by the Board of Directors.

Item 11. EXECUTIVE COMPENSATION

(a) (b)  Summary Compensation Table:

<TABLE>
<CAPTION>
                                                                 Long Term Compensation
                                  Annual Compensation                  Awards                Payouts
(a)                (b)         (c)         (d)       (e)         (f)          (g)          (h)        (i)
                                                    Other     Restricted    Securities                All             
                                                   Annual        Stock      underlying               other            
Name and                                           Compen-      Award(s)     Options/      LTIP      Compen-
Principal         Year        Salary      Bonus    sation                     SAR's       Payouts    sation
Position          Ended         ($)        ($)       ($)          ($)          ($)          ($)       ($)
- ------------------------------------------------------------------------------------------------------------
<S>               <C>         <C>         <C>         <C>        <C>           <C>         <C>      <C>
Stephen E.
Globus,
CEO               2/28/97     50,000       --         --          --            --          --       --
                  2/29/96     50,000       --         --          --            --          --       --
                  2/28/95     50,000       --         --          --            --          --       --
</TABLE>

(c) Option/SAR Grants Table -- Not Applicable.

(d) Aggregated  Option/SAR  Exercises and Fiscal Year-End Option/SAR Value Table
     -- Not Applicable.

(e) Long-Term Incentive Plan ("LTIP") Awards Table -- Not Applicable.

(f) Defined Benefit or Actuarial Plan Disclosure -- Not Applicable.

(g) Compensation of Directors -- There are presently no arrangements pursuant to
which Directors of the Company are  compensated  for any services  provided as a
director,  including any amounts payable for committee  participation or special
assignments.

(h) Employment  Contracts and  Termination  of Employment and  Change-In-Control
Arrangements -- Not Applicable.

(i)  Report on Repricing of Options/SAR's -- Not Applicable.

(j) Compensation  Committee Interlocks and Insider Participation -- The Board of
Directors  of the  Company  did not have  any  compensation  committee  or board
committee performing equivalent functions during the last completed fiscal year.
Messrs.  Stephen E. and Richard D. Globus  participated in all deliberations and
decisions  of the Board of Directors  of the Company  during its last  completed
fiscal year.

(k) Board Compensation Committee Report on Executive Compensation
     -- Not Applicable.

(l) Performance Graph -- Not Applicable.

<PAGE>


Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information as of May 7, 1997,  regarding
each  person  known  by the  Company  to own  beneficially  more  than 5% of the
Company's  Common Stock,  each director of the Company who owns shares of Common
Stock, and all directors and officers as a group.

                                                                     Approximate
                                           Amount and Nature of        Percent
         Name                            Beneficial Ownership (1)   of Class (2)
         ----                            ------------------------   ------------

Stephen E. Globus*                             514,750(3)                22
Richard D. Globus*                             513,750                   22
Ronald P. Globus*                              500,000                   22
Ronald J. Frank                                  1,000                   (4)
Stanley Wunderlich                                none                   --
Joseph Mancuso                                    none                   --
                                                                    
All Directors and Officers                                          
   as a Group (7 persons)                    1,048,200                   44(2)
                                                                    
Jane Globus                                                         
201 Crandon Blvd                                                    
Key Biscayne, FL 33149                         312,292(5)                13
                                                                    
* 44 West 24th Street, New York, NY  10010                        

(1) Unless  otherwise  indicated,  all shares are directly  owned,  and the sole
investment and voting power is held, by the persons named.  Information in table
has been  supplied by the persons  concerned or has been  obtained  from Company
records.

(2) Approximate percent of class has been computed on the basis of the number of
shares of Common Stock outstanding as of May 1, 1997, (2,364,860).

(3) Includes 1,000 shares held for benefit of minor son.

(4) Less than 1%.

(5) 16,500  shares are held of record and  beneficially  and the  remainder  are
beneficially  owned.  Mrs. Globus is the mother of the three Globus brothers who
disclaim any beneficial ownership of the shares owned by her.

Item 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
 
(i) From time to time  Messrs.  Stephen E. and Richard D. Globus have made loans
to the  Company.  During the past fiscal year of the Company  they made loans of
$11,000. For details as to amounts owed to them by the Company, reference should
be made to the  caption  "Management's  Discussion  and  Analysis  of  Financial
Condition and Results of Operations" elsewhere herein. Commencing March 1, 1988,
loans  owing to Mr.  Stephen  E.  Globus  (the  principal  amount  of which  was
approximately  $215,000  at such date)  accrued  interest  at the rate of 5% per
annum (which is the same rate of interest paid on loans owing to Mr.  Richard D.
Globus).  The  Company is also  indebted  to Messrs.  Stephen E. and  Richard D.
Globus for unpaid  salaries  owed to them and is indebted to Ms. Jane Globus for
monies loaned to it by her. For details as to amounts owed  reference  should be
made to the caption "Management's Discussion and Analysis of Financial Condition
and Results of Operations" elsewhere herein.


<PAGE>


(ii) During the past fiscal year Messrs.  Stephen E. and Richard D.  Globus,  as
applicable, agreed to offset a total of $66,000 of monies owed to one or both of
them by the  Company in return for the  personal  use by one or both of such two
persons of facilities, personnel and other services of the Company.


                                     PART IV

Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

(a) (1) (2) Financial Statements and Financial Statement Schedules

     A list of the Financial  Statements and Financial Statement Schedules filed
as a part of this  Report is set forth in Item 8 of this  Report,  which list is
incorporated herein by reference.

(a) (3) Exhibits

     3(a) Articles of  Incorporation  and Amendments  Thereto  (Incorporated  by
          reference to Exhibits 2(a), 2(b) and 2(c) filed with Registrant's Form
          S-18  Registration  Statement,  File # 2-72220 NY and to  Exhibit  3-1
          filed with  Registrant's  Form 8-K for event of August 7,  1984,  File
          #0-9987.

     3(b) By-Laws   (Incorporated  by  reference  to  Exhibit  2(d)  filed  with
          Registrant's Form S-18 Registration Statement, File # 2-72220 NY.

     10   Sale of Assets  Agreement  between  Registrant  and Idex,  Inc.  dated
          December  11,  1985   (Incorporated  by  reference  to  Exhibit  1  to
          Registrant's Form 8-K for event of February 27, 1986).

     11   Statement re computation of per share earnings. (Included in Note F of
          Notes To Financial Statements filed as part of this Report).

(b)  Reports on Form 8-K

     During the last quarter of the period covered by this Report, no reports on
     Form 8-K were filed.

<PAGE>


                                   SIGNATURES

     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                                     GLOBUS GROWTH GROUP, INC.



                                                      By   /s/ Stephen E. Globus
                                                          --------------------- 
                                                          Stephen E. Globus
                                                          Chairman of the Board

Dated:  New York, NY
        May 29, 1997

     Pursuant to the  requirements of the Securities  Exchange Act of 1934, this
report has been signed below by the following  persons in the  capacities and on
the dated indicated:

     Signature                          Title                          Date
     ---------                          -----                          ----

s/Stephen E. Globus            Chairman of the Board,
- -----------------------        (Principal Executive Officer)        May 29, 1997
Stephen E. Globus              


s/Richard D. Globus            President, Director                  May 29, 1997
- -----------------------
Richard D. Globus


s/Lisa Vislocky                Treasurer (Principal Financial &
- -----------------------        Accounting Officer)                  May 29, 1997
Lisa Vislocky                  


s/Stanley Wunderlich           Director                             May 29, 1997
- ----------------------- 
Stanley Wunderlich


s/Ronald J. Frank              Director                             May 29, 1997
- ----------------------- 
Ronald J. Frank


s/Joseph Mancuso               Director                             May 29, 1997
- ----------------------- 
Joseph Mancuso



                                       S-1

<PAGE>
                                                Richard A. Eisner & Company, LLP
- --------------------------------------------------------------------------------
                                                     Accountants and Consultants

[LOGO]



                         REPORT OF INDEPENDENT AUDITORS



Board of Directors and Shareholders
Globus Growth Group, Inc.
New York, New York


     We have audited the accompanying balance sheets of Globus Growth Group,
Inc. as at February 28, 1997 and February 29, 1996, and the related statements
of operations, changes in shareholders' equity and cash flows for each of the
years in the three-year period ended February 28, 1997. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

     We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

     In our opinion, the financial statements enumerated above present fairly,
in all material respects, the financial position of Globus Growth Group, Inc. at
February 28, 1997 and February 29, 1996, and the results of its operations and
its cash flows for each of the years in the three-year period ended February 28,
1997 in conformity with generally accepted accounting principles.



                                       F-1


                 575 Madison Avenue, New York, N.Y. 10022-2597
                Member of Summit International Associates, Inc.
New York, NY    o    Melville, NY    o    Cambridge, MA    o    Florham Park, NJ



<PAGE>


- --------------------------------------------------------------------------------


[LOGO]


     As explained in Note B, the financial statements include securities valued
at $1,654,000 at February 28, 1997 (50% of assets) and $660,000 at February 29,
1996 (25% of assets), whose values have been estimated by the Board of Directors
in the absence of readily ascertainable market values. We have reviewed the
procedures used by the Board of Directors in arriving at its estimate of value
of such securities and have inspected underlying documentation, and, in the
circumstances, we believe the procedures are reasonable and the documentation
appropriate. However, because of the inherent uncertainty of valuation, those
estimated values may differ significantly from the values that would have been
used had a ready market for the securities existed, and the differences could be
material.


/s/ Richard A. Eisner & Company, LLP

New York, New York
May 5, 1997


                                       F-2

<PAGE>



                            GLOBUS GROWTH GROUP, INC.

                                 BALANCE SHEETS
                                    (Note A)



                                                     February 28,   February 29,
                                                        1997           1996
                                                     -----------    -----------

                    A S S E T S 
                    ----------- 

Cash .............................................   $   512,000    $   985,000
Investments in securities (Notes A[2] and B)  ....     2,737,000      1,690,000
Promissory note receivable (Note C) ..............        50,000
Other assets .....................................        19,000         16,000
                                                     -----------    -----------


          T O T A L ..............................   $ 3,318,000    $ 2,691,000
                                                     ===========    ===========


               L I A B I L I T I E S
               ---------------------

Accounts payable and accrued expenses,
   including salary due to officer/
   shareholders of $860,000 in 1997 and
   $760,000 in 1996 ..............................   $   910,000    $   808,000
Loans payable to officer/shareholders,
   including accrued interest of $205,000 in
   1997 and $186,000 in 1996 (Note D) ............       528,000        660,000
Loan payable to related party, including
   accrued interest of $93,000 in 1997 and
   $77,000 in 1996 (Note D) ......................       405,000        394,000
                                                     -----------    -----------

          Total liabilities ......................     1,843,000      1,862,000
                                                     -----------    -----------


               SHAREHOLDERS' EQUITY
               --------------------
                     (Note F)

Preferred stock - $.10 par value; authorized
   450,000 shares; none issued
Series B convertible preferred stock - $.10
   par value; authorized 50,000 shares;
   none issued
Common stock - $.01 par value; authorized
   4,500,000 shares; issued 2,499,000 shares .....        25,000         25,000
Additional paid-in capital .......................     2,747,000      2,747,000
Accumulated deficit ..............................    (1,260,000)    (1,907,000)
Treasury stock, at cost - 134,140 shares
   in 1997 and 133,140 shares in 1996 ............       (37,000)       (36,000)
                                                     -----------    -----------


          Total shareholders' equity .............     1,475,000        829,000
                                                     -----------    -----------


          T O T A L ..............................   $ 3,318,000    $ 2,691,000
                                                     ===========    ===========


                 The accompanying notes to financial statements
                          are an integral part hereof.


                                       F-3


<PAGE>



                            GLOBUS GROWTH GROUP, INC.

                            STATEMENTS OF OPERATIONS
                                    (Note A)



                                                      Year Ended
                                        ----------------------------------------
                                        February 28,  February 29,  February 28,
                                           1997          1996           1995
                                        -----------   -----------   ------------

Gain on investments:

   Realized .........................   $    46,000   $   859,000   $   203,000

   Unrealized .......................       773,000       445,000        22,000
                                        -----------   -----------   -----------


          T o t a l .................       819,000     1,304,000       225,000

Interest and dividend income ........        42,000         8,000         8,000

Consulting and other income
   (including approximately
   $14,000 in 1997, $25,000 in
   1996 and $11,000 in 1995
   from related parties)  ...........        50,000        68,000        25,000
                                        -----------   -----------   -----------


          T o t a l .................       911,000     1,380,000       258,000
                                        -----------   -----------   -----------


Expenses:

   General and administrative
     (Note H) .......................       229,000       197,000       237,000

   Interest .........................        35,000        53,000        50,000
                                        -----------   -----------   -----------


          T o t a l .................       264,000       250,000       287,000
                                        -----------   -----------   -----------


NET INCOME (LOSS) ...................   $   647,000   $ 1,130,000   $   (29,000)
                                        ===========   ===========   ===========



NET INCOME (LOSS) PER SHARE
   (NOTE G) .........................   $       .27   $       .47   $      (.01)
                                        ===========   ===========   ===========



Weighted average number of
   common shares ....................     2,364,964     2,380,208     2,395,477
                                        ===========   ===========   ===========


                 The accompanying notes to financial statements
                          are an integral part hereof.

                                       F-4

<PAGE>



<TABLE>
<CAPTION>
                                                      GLOBUS GROWTH GROUP, INC.

                                            STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY



                                                           Common Stock                                           Treasury Stock
                                                    -----------------------   Additional                      ----------------------
                                                    Number of                   Paid-in     Accumulated       Number of
                                                      Shares       Amount       Capital       Deficit          Shares       Cost
                                                    ---------   -----------   -----------   -----------        -------   -----------

<S>                                                 <C>         <C>           <C>           <C>                <C>       <C>        
Balance - February 28, 1994 ...................     2,499,000   $    25,000   $ 2,747,000   $(3,008,000)       101,190   $    34,000


Net (loss) ....................................                                                 (29,000)


Acquisition of treasury shares, $.06 per
   share ......................................                                                                  3,300
                                                    ---------   -----------   -----------   -----------        -------   -----------


Balance - February 28, 1995 ...................     2,499,000        25,000     2,747,000    (3,037,000)       104,490        34,000


Net income ....................................                                               1,130,000


Acquisition of treasury shares, $.05 per
   share ......................................                                                                 17,200         1,000


Exchange for treasury shares, $.10 per share ..                                                                 11,450         1,000
                                                    ---------   -----------   -----------   -----------        -------   -----------



Balance - February 29, 1996 ...................     2,499,000        25,000     2,747,000    (1,907,000)       133,140        36,000


Net income ....................................                                                 647,000


Acquisition of treasury shares, $.16 per
   share                                                                                                         1,000         1,000
 ..............................................     ---------   -----------   -----------   -----------        -------   -----------


BALANCE - FEBRUARY 28, 1997  ..................     2,499,000   $    25,000   $ 2,747,000   $(1,260,000)       134,140   $    37,000
                                                    =========   ===========   ===========   ===========        =======   ===========
</TABLE>


                 The accompanying notes to financial statements
                          are an integral part hereof.

                                       F-5

<PAGE>



                                                      GLOBUS GROWTH GROUP, INC.

                                                      STATEMENTS OF CASH FLOWS


<TABLE>
<CAPTION>
                                                                                                        Year Ended
                                                                                       ---------------------------------------------
                                                                                       February 28,     February 29,    February 28,
                                                                                           1997            1996             1995
                                                                                       ------------     -----------     -----------
<S>                                                                                     <C>             <C>             <C>         
Cash flows from operating activities:
   Net income (loss) ...............................................................    $   647,000     $ 1,130,000     $   (29,000)
   Adjustments to reconcile net income (loss) to net cash (used in)
     operating activities:
       Depreciation and amortization ...............................................          1,000           2,000           2,000
       Realized (gain) on investments ..............................................        (46,000)       (859,000)       (203,000)
       Unrealized (gain) on investments ............................................       (773,000)       (445,000)        (22,000)
       (Increase) in other assets ..................................................         (3,000)         (5,000)
       Increase in accounts payable, accrued expenses and accrued
         interest on loans .........................................................        137,000          87,000         103,000
                                                                                        -----------     -----------     -----------
           Net cash (used in) operating activities .................................        (37,000)        (90,000)       (149,000)
                                                                                        -----------     -----------     -----------

Cash flows from investing activities:
   Purchase of investments .........................................................       (280,000)       (335,000)       (190,000)
   Proceeds from sale of investments ...............................................         52,000       1,498,000         433,000
   Promissory note receivable ......................................................        (50,000)
                                                                                        -----------     -----------     -----------
           Net cash provided by (used in) investing activities .....................       (278,000)      1,163,000         243,000
                                                                                        -----------     -----------     -----------

Cash flows from financing activities:
   Purchase of treasury stock ......................................................         (1,000)         (2,000)
   Borrowings from (repayments to) related party ...................................         (5,000)          9,000          (4,000)
   Increase in loans payable to officer/shareholders ...............................         11,000          26,000          33,000
   Repayment of loans payable to officer/shareholders ..............................       (163,000)       (127,000)       (117,000)
                                                                                        -----------     -----------     -----------
           Net cash (used in) financing activities .................................       (158,000)        (94,000)        (88,000)
                                                                                        -----------     -----------     -----------

NET INCREASE (DECREASE) IN CASH ....................................................       (473,000)        979,000           6,000

Cash - beginning of year ...........................................................        985,000           6,000           - 0 -
                                                                                        -----------     -----------     -----------

CASH - END OF YEAR .................................................................    $   512,000     $   985,000     $     6,000
                                                                                        ===========     ===========     ===========


Supplemental disclosures of cash flow information: 
   Cash paid during the year for:
     Income taxes ..................................................................    $    11,000     $       700     $       700
     Interest ......................................................................                         11,000             600
 
Noncash investing activity:
   Securities sold for which cash was not received .................................           $-0-     $     1,000     $    62,000
</TABLE>


                 The accompanying notes to financial statements
                          are an integral part hereof.

                                       F-6

<PAGE>


                            GLOBUS GROWTH GROUP, INC.

                          NOTES TO FINANCIAL STATEMENTS


(NOTE A) - The Company and Its Significant Accounting Policies:

     [1] The Company:

     The Company's principal activity is investing in other companies. Effective
May 27, 1988, the Company elected to be treated as a Business Development
Company.

     The Company's principal assets are its investments which, unless sold, do
not generate any cash flow. As a result, the Company has been dependent upon
advances from its officer/shareholders in order to meet its obligations. The
Company's ability to continue to meet its obligations is dependent upon a ready
market for its investments or upon the continued financial support of the
officer/shareholders including their willingness to refrain from demanding
amounts due them.

     [2] Security valuation:

     Investments are carried at fair value, which, for readily marketable
securities, represents the last reported sales price or bid price on the
valuation date. Investments in restricted securities and securities which are
not readily marketable are carried at fair value as determined in good faith by
the Board of Directors, in the exercise of its judgment, after taking into
consideration various indications of value available to the Board.

(continued)


                                       F-7

<PAGE>


                            GLOBUS GROWTH GROUP, INC.

                          NOTES TO FINANCIAL STATEMENTS




(NOTE B) - Investments:

<TABLE>
<CAPTION>
                                                                       February 28, 1997                    February 29, 1996
                                                               ---------------------------------   ---------------------------------
                                                                Number       Fair                   Number      Fair
                        Security                               of Shares     Value       Cost      of Shares    Value         Cost
- ------------------------------------------------------------   ---------  ----------  ----------   ---------  ----------    --------
<S>                                                              <C>      <C>         <C>             <C>     <C>           <C>     
Common stock - 89.8% in 1997 and 84.3% in 1996:
   Catamount Brewing Co. (1) ...............................      23,215  $  569,000  $  176,000      23,215  $  176,000    $176,000
   Interface Systems Inc. ..................................         775       4,000       7,000         775      12,000       7,000
   Nematron Corporation ....................................      16,925     110,000      30,000      16,925     127,000      30,000
   Energy Research, Inc. (2) ...............................      76,000     883,000      88,000      81,000     891,000      94,000
   Kimeragen, Inc. (3) .....................................                                             414      70,000      70,000
   Kimeragen, Inc. C1ass A (3) .............................     108,827     609,000     219,000      55,000     149,000     149,000
   Kimeragen, Inc. C1ass B (3) .............................      35,000     196,000      75,000
   Repligen Corporation (4) ................................     100,468      86,000     190,000
                                                                          ----------  ----------              ----------    --------

          Total common stock ...............................               2,457,000     785,000               1,425,000     526,000
                                                                          ----------  ----------              ----------    --------

Preferred shares - 10.2% in 1997 and 14.2% in 1996:
   Kimeragen, Inc. - Preferred (3) .........................                                             113      75,000      75,000
   Proscure Inc. - Series A convertible preferred (4) ......                                          61,000      86,000      86,000
   Proscure Inc. - Series B convertible preferred (4) ......                                          53,334      80,000      80,000
   Catamount Brewing Co. - Preferred .......................     260,000     150,000     150,000
   Genitope Corp. - Series A preferred .....................       4,286     130,000     130,000
                                                                          ----------  ----------              ----------    --------

          Total preferred stock ............................                 280,000     280,000                 241,000     241,000
                                                                          ----------  ----------              ----------    --------


Stock purchase warrants - 0% in 1997 and 1.5% in 1996:
   Glycan Pharmaceuticals Inc. (4) .........................                                          37,500      17,000      17,000
   Proscure Inc. (4) .......................................                                          75,000       7,000       7,000
                                                                          ----------  ----------              ----------    --------

                                                                              - 0 -       - 0 -                   24,000      24,000
                                                                          ----------  ----------              ----------    --------

          Total investments - fair value ...................              $2,737,000  $1,065,000              $1,690,000    $791,000
                                                                          ==========  ==========              ==========    ========
</TABLE>


Restricted and not readily marketable securities were valued at a total fair
   value of $1,654,000 and $660,000 at February 28, 1997 and February 29, 1996,
   respectively, as determined by the Board of Directors. Such investments
   consisted of all securities except Interface Systems Inc., Nematron
   Corporation, Energy Research, Inc. and Repligen Corp. in 1997 and in 1996 for
   which values are based on quoted market values.

The Company invests in energy technology, biotechnology, beverage company and
   computer technology, 33%, 37%, 26% and 4%, respectively, at February 28, 1997
   and 53%, 29%, 10% and 8%, respectively, at February 29, 1996. All investments
   are in U.S. companies.

All investments are nonincome producing except Interface Systems Inc. in 1996.



(continued)


                                       F-8

<PAGE>


                            GLOBUS GROWTH GROUP, INC.

                          NOTES TO FINANCIAL STATEMENTS


(NOTE B) - Investments:  (continued)

     (1) Represents in excess of 5% of outstanding voting securities of
investee.

     (2) Subject to the provisions of Rule 144(k) under the Securities Act of
1933.

     (3) During the year ended February 28, 1997 113 shares of preferred stock
were exchanged for 35,000 shares of Class B common stock and 414 shares of
common stock were exchanged for 53,827 shares of Class A common stock.

     (4) During the year ended February 28, 1997 all of the preferred stock was
exchanged for 91,468 shares of Repligen Corporation common stock and all of the
Proscure Inc. and Glycan Pharmaceuticals Inc. warrants were exchanged for 9,000
shares of Repligen Corporation common stock.

     Cost indicated above is tax cost. The unrealized appreciation and
depreciation is as follows:


                                                 February 28,       February 29,
                                                    1997                1996
                                                 -----------         -----------
Unrealized appreciation .................        $ 1,779,000         $   899,000

Unrealized (depreciation) ...............           (107,000)
                                                 -----------         -----------
          Net appreciation ..............        $ 1,672,000         $   899,000
                                                 ===========         ===========


(NOTE C) - Promissory Note Receivable:

     In November 1996 the Company loaned $50,000 to Woodstock Communications
Inc. The loan matures on the earlier of the date of consummation of a financing,
as defined, on November 19, 1998. The loan bears interest, determinable at the
option of the Company, either at 10% per annum or the issuance of Class A common
stock of the borrower equaling a 1% ownership interest, as defined.


(NOTE D) - Loans Payable:

     Loans from officer/shareholders and a relative of theirs are due on demand
and bear annual interest at 5%.

     The estimated fair value of these financial instruments is not readily
determinable due to the nature of the relationship of the parties. The amounts
presented are not necessarily indicative of the amounts that could be realized
in a current market exchange.

(continued)


                                       F-9

<PAGE>


                            GLOBUS GROWTH GROUP, INC.

                          NOTES TO FINANCIAL STATEMENTS


(NOTE E) - Income Taxes:

     The current provision for income taxes for the year ended February 28, 1997
in the amount of approximately $295,000 equals the amount of the reduction in
the valuation allowance on the deferred tax asset. As of February 28, 1997, the
Company has approximately $871,000 of net operating loss carryforwards to reduce
taxable income. Such carryforwards expire in fiscal years ending in February
2000 through February 2011.

     Temporary differences and carryforwards which give rise to the net deferred
tax asset are as follows:


                                                      February 28,  February 29,
                                                          1997          1996
                                                      ------------  ------------
Net operating loss
   carryovers .....................................    $ 401,000      $ 402,000
Unrealized gain on                                                   
   investments ....................................     (769,000)      (414,000)
Accrued expenses not yet                                             
   deductible for income tax                                         
   purposes .......................................      533,000        472,000
                                                       ---------      ---------
                                                                     
                                                         165,000        460,000
Less valuation allowance                                             
   thereon ........................................      165,000        460,000
                                                       ---------      ---------
                                                                    
                                                       $  - 0 -       $  - 0 -
                                                       =========      =========


(NOTE F) - Shareholders' Equity:

     The Board of Directors has authorized the future sale of up to 300,000
shares of the Company's authorized, but unissued, common stock at a price of
$.50 per share to individuals to be determined at the discretion of the Board.
No such shares have been issued.


(NOTE G) - Per Share Data:

     Per share data are based on the weighted average number of shares of common
stock outstanding.



(continued)


                                      F-10

<PAGE>


                            GLOBUS GROWTH GROUP, INC.

                          NOTES TO FINANCIAL STATEMENTS

(NOTE H) - Related Party Transactions:

     The Company paid approximately $14,000 for rent to a related party for the
year ended February 28, 1997 and approximately $13,000 for each of the years
ended February 29, 1996 and February 28, 1995.

     The Company charged two officer/shareholders $66,000 as reimbursement for
general and administrative costs and for their use of the Company's office and
personnel during each of the years ended February 28, 1997, February 29, 1996,
and February 28, 1995.


                                      F-11


<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary financial  information  extracted from Form
10K at February  28, 1997 and is  qualified in its entirety by reference to such
financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              FEB-28-1997
<PERIOD-END>                                   Feb-28-1997
<CASH>                                         512,000
<SECURITIES>                                   2,737,000
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         24,000
<DEPRECIATION>                                 22,000
<TOTAL-ASSETS>                                 3,318,000
<CURRENT-LIABILITIES>                          1,843,000
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       25,000
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   1,475,000
<SALES>                                        0
<TOTAL-REVENUES>                               911,000
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               229,000
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             35,000
<INCOME-PRETAX>                                647,000
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            647,000
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   647,000
<EPS-PRIMARY>                                  0.27
<EPS-DILUTED>                                  0.27
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission